Literature DB >> 1525069

Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.

T C Thompson1, S Egawa, D Kadmon, G J Miller, T L Timme, P T Scardino, S H Park.   

Abstract

We established an androgen-sensitive cell line (BR31-5) from a ras + myc-induced mouse prostate carcinoma and used this cell line together with a previously reported transplantable androgen-independent mouse prostate carcinoma to investigate patterns of expression for apoptosis-related genes in an androgen-deprived environment. Single cell suspensions derived from the BR31-5 cell line were inoculated into the flank of intact or castrated adult male C57BL/6 mice and tumors were harvested 12 days post-inoculation for Northern blotting. A transplantable androgen-independent prostate cancer was also inoculated into intact or castrated mice and tumors harvested 21 days later. Tumor volume analyses showed that BR31-5 carcinomas were androgen-sensitive. Northern blotting showed that mRNA levels for two apoptosis-related genes, transforming growth factor-beta 1 and c-myc, were significantly elevated to a similar extent in carcinomas grown in castrated hosts compared to intact hosts for both the androgen-sensitive BR31-5 and androgen-independent carcinomas. Levels of mRNA for tissue type plasminogen activator, shown previously to be elevated in androgen-independent carcinomas following growth in castrates, were also increased in BR31-5 carcinomas under similar androgen-deprived conditions but to a lesser extent. Interestingly, testosterone repressed prostate mRNA No. 2 levels shown previously to be similar in both the intact and castrated groups for androgen-independent carcinomas were significantly increased in the castrated group compared to the intact group for BR31-5 carcinomas. Therefore, specific patterns of expression for apoptosis-related genes may be able to discriminate androgen-sensitive and androgen-independent prostate cancer under androgen-deprived conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525069     DOI: 10.1016/0960-0760(92)90190-t

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

1.  Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.

Authors:  G Sehgal; J Hua; E J Bernhard; I Sehgal; T C Thompson; R J Muschel
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

2.  Identification and comparative analysis of human colonocyte short-chain fatty acid response genes.

Authors:  M D Basson; Y W Liu; A M Hanly; N J Emenaker; S G Shenoy; B E Gould Rothberg
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

3.  1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.

Authors:  JoyAnn N Phillips Rohan; Nancy L Weigel
Journal:  Endocrinology       Date:  2009-01-22       Impact factor: 4.736

4.  Rapamycin enhances adenovirus-mediated cancer imaging and therapy in pre-immunized murine hosts.

Authors:  Ziyue Karen Jiang; Mai Johnson; Diana L Moughon; Jennifer Kuo; Makoto Sato; Lily Wu
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.